Glenn Muir - Rewalk Robotics Independent Director
| RWLKDelisted Stock | USD 1.05 0.04 3.96% |
Director
Mr. Glenn P. Muir was Independent Director of ReWalk Robotics Ltd. He has served on our Board since 2014 as an external director under the Israeli Companies Law. Until May 2014, Mr. Muir served as Executive Vice President, Finance and Administration of Hologic, Inc. since September 2000 and as Chief Financial Officer since 1992. Hologic is a manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products with an emphasis on serving the healthcare needs of women. Prior to that, Mr. Muir served as the Controller of Hologic from the time he joined in October 1988 through 1992, including during its initial public offering in 1990. Since 2015 Mr. Muir was a director and member of the audit and compensation committees of Repligen Corporation, and was a director and chairman of the audit committee of each of RainDance Technologies, Inc. since 2014 and G1 Therapeutics, Inc. since 2015. Additionally, Mr. Muir served as a director of Hologic from 2001 through 2013. Mr. Muir holds a B.B.A. with a major in accounting from the University of Massachusetts in Amherst, an M.B.A. from the Harvard Graduate School of Business Administration and an M. Sc. in taxation from Bentley College Graduate School of Business. Mr. Muir is also a certified public accountant.
| Age | 57 |
| Phone | 972 4 959 0123 |
| Web | https://www.rewalk.com |
Glenn Muir Latest Insider Activity
Tracking and analyzing the buying and selling activities of Glenn Muir against Rewalk Robotics stock is an integral part of due diligence when investing in Rewalk Robotics. Glenn Muir insider activity provides valuable insight into whether Rewalk Robotics is net buyers or sellers over its current business cycle. Note, Rewalk Robotics insiders must abide by specific rules, including filing SEC forms every time they buy or sell Rewalk Robotics'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Glenn Muir over six months ago Acquisition by Glenn Muir of 36364 shares of Neuronetics subject to Rule 16b-3 |
Rewalk Robotics Management Efficiency
The company has return on total asset (ROA) of (0.1665) % which means that it has lost $0.1665 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3424) %, meaning that it created substantial loss on money invested by shareholders. Rewalk Robotics' management efficiency ratios could be used to measure how well Rewalk Robotics manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 897 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Rewalk Robotics has a current ratio of 21.61, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Rewalk Robotics until it has trouble settling it off, either with new capital or with free cash flow. So, Rewalk Robotics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Rewalk Robotics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Rewalk to invest in growth at high rates of return. When we think about Rewalk Robotics' use of debt, we should always consider it together with cash and equity.
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel. Rewalk Robotics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 51 people. Rewalk Robotics (RWLK) is traded on NASDAQ Exchange in USA and employs 56 people. Management Performance
| Return On Equity | -0.34 | |||
| Return On Asset | -0.17 |
Rewalk Robotics Leadership Team
Elected by the shareholders, the Rewalk Robotics' board of directors comprises two types of representatives: Rewalk Robotics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rewalk. The board's role is to monitor Rewalk Robotics' management team and ensure that shareholders' interests are well served. Rewalk Robotics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rewalk Robotics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA BS, CEO Director | ||
| Jeff Dykan, Independent Chairman of the Board | ||
| Jay Kalish, Independent Director | ||
| John Hamilton, Vice President - Regulatory and Clinical | ||
| Miri Pariente, Global Director - Quality | ||
| Yohanan Engelhardt, Director | ||
| Charles Remsberg, Chief Officer | ||
| Glenn Muir, Independent Director | ||
| Wayne Weisman, Independent Director | ||
| Kevin Hershberger, CFO | ||
| Michael Lawless, Chief Officer | ||
| Deborah DiSanzo, Director | ||
| Lawrence Jasinski, CEO, Director | ||
| Ofir Koren, VP of RandD | ||
| Ning Cong, Independent Director | ||
| Ami Kraft, Ex CEO | ||
| Asaf Shinar, Independent Director | ||
| Judy Kula, Human Service | ||
| John Poduska, Independent Director Nominee | ||
| Ori Gon, CFO | ||
| Ori Schellas, Director of Operations | ||
| Aryeh Dan, Director | ||
| David Hexner, VP RD | ||
| Chunlin Han, Director | ||
| Kathleen ODonnell, Vice Development | ||
| Larry Jasinski, CEO, Director | ||
| Jodi Gricci, VP of Global Marketing | ||
| Hadar Ron, Independent Director | ||
| Peter Wehrly, Independent Director | ||
| Yasushi Ichiki, Director | ||
| Jeannine Lynch, Vice Strategy |
Rewalk Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Rewalk Robotics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.34 | |||
| Return On Asset | -0.17 | |||
| Profit Margin | (2.38) % | |||
| Operating Margin | (1.24) % | |||
| Current Valuation | 28.94 M | |||
| Shares Outstanding | 60.02 M | |||
| Shares Owned By Insiders | 1.96 % | |||
| Shares Owned By Institutions | 20.71 % | |||
| Number Of Shares Shorted | 1.36 M | |||
| Price To Earning | (0.77) X |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Rewalk Stock
If you are still planning to invest in Rewalk Robotics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rewalk Robotics' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |